Nang Kuang Pharmaceutical Balance Sheet

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Jun '26 Jun 30, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	363.56	345.67	301.54	378.48	401.2	417.12
Trading Asset Securities	-	-	-	-	1.31	1.28
Cash & Short-Term Investments	383.56	345.67	301.54	378.48	402.51	418.41
Cash Growth	23.93%	14.63%	-20.33%	-5.97%	-3.80%	56.21%
Accounts Receivable	398.49	363.56	423.08	374.67	386.71	350.44
Other Receivables	0.13	0.98	0.12	1.3	0.15	0.4
Receivables	398.62	364.54	423.2	375.97	386.86	350.84
Inventory	704.1	731.56	709.06	762.62	827.58	701.44
Prepaid Expenses	95.48	24.23	20.36	20.61	23.38	20.71
Other Current Assets	22.82	26.61	1.83	-	-	-
Total Current Assets	1,605	1,493	1,456	1,538	1,640	1,491
Property, Plant & Equipment	2,130	2,089	2,105	1,867	1,602	1,682
Long-Term Investments	98.9	114.81	129.12	152.18	118.97	50.29
Other Intangible Assets	8.76	5.28	4.34	5.2	3.87	5.21
Long-Term Deferred Tax Assets	25.28	25.39	22.02	39.36	27.07	29.84
Other Long-Term Assets	73.64	96.68	95.99	255.08	192.61	169.83
Total Assets	3,941	3,823	3,813	3,856	3,585	3,429
Accounts Payable	210.73	211.55	210.38	166.8	254.3	224.34
Accrued Expenses	-	122.32	113.99	100.61	-	-
Short-Term Debt	340	460	450	580	370	479.99
Current Portion of Long-Term Debt	39.29	8.93	19.86	12.5	12.5	12.5
Current Portion of Leases	0.47	0.37	0.75	0.49	1.05	1.26
Current Income Taxes Payable	26.83	22.64	11.78	2.7	57.01	46.61
Current Unearned Revenue	100.97	121.42	123.9	127.97	142.49	131.55
Other Current Liabilities	422.97	117.55	212.17	291.63	203.04	176.7
Total Current Liabilities	1,141	1,065	1,143	1,283	1,040	1,073
Long-Term Debt	301.87	186.39	167.26	112.5	25	37.5
Long-Term Leases	3.01	-	0.37	0.07	0.59	1.55
Pension & Post-Retirement Benefits	-	51.75	50.01	53.71	53	53.36
Long-Term Deferred Tax Liabilities	0.31	0.68	0.35	-	1.2	0.26
Other Long-Term Liabilities	82.77	30.1	30.1	30.1	53.33	23.06
Total Liabilities	1,529	1,334	1,391	1,479	1,174	1,189
Common Stock	1,010	1,010	1,010	1,010	1,010	1,010
Additional Paid-In Capital	164.22	245.01	325.8	426.79	457.09	482.34
Retained Earnings	1,233	1,229	1,086	940.46	944.03	748.02
Comprehensive Income & Other	-0.04	-0.04	-0.04	-0.03	0.02	-0.04
Total Common Equity	2,407	2,484	2,422	2,377	2,411	2,240
Minority Interest	4.36	5.53	-	-	-	-
Shareholders' Equity	2,412	2,490	2,422	2,377	2,411	2,240
Total Liabilities & Equity	3,941	3,823	3,813	3,856	3,585	3,429
Total Debt	684.64	655.69	638.23	705.56	409.13	532.81
Net Cash (Debt)	-301.09	-310.02	-336.69	-327.08	-6.62	-114.4
Net Cash Growth	-	-	-	-	-	-
Net Cash Per Share	-3.00	-3.06	-3.33	-3.23	-0.07	-1.13
Filing Date Shares Outstanding	99.5	100.99	100.99	100.99	100.99	100.99
Total Common Shares Outstanding	99.5	100.99	100.99	100.99	100.99	100.99
Working Capital	463.32	427.82	313.17	254.99	599.94	418.44
Book Value Per Share	24.20	24.60	23.98	23.54	23.87	22.18
Tangible Book Value	2,399	2,479	2,418	2,372	2,407	2,235
Tangible Book Value Per Share	24.11	24.55	23.94	23.49	23.84	22.13
Land	-	757.96	767.41	573.57	247.28	247.28
Buildings	-	1,223	1,232	1,134	1,120	1,111
Machinery	-	2,698	2,586	2,506	2,431	2,359
Construction In Progress	-	109	56.54	26.79	36.53	41.57